Cue Biopharma, Inc. (CUE) Total liabilities 2018–2025
Cue Biopharma, Inc. (CUE) total liabilities at each fiscal year-end, per SEC filings.
$15.8MFY2025 · since FY2018: $11.4M → $15.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.8M | +7.4% |
| FY2024 | $14.7M | -39.9% |
| FY2023 | $24.4M | -4.5% |
| FY2022 | $25.6M | +43.0% |
| FY2021 | $17.9M | -13.2% |
| FY2020 | $20.6M | +21.2% |
| FY2019 | $17.0M | +49.4% |
| FY2018 | $11.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice